PMV Pharmaceuticals Inc (PMVP) EPS growth this year is 3.33%: Get Prepared for Trading Lift Off

PMV Pharmaceuticals Inc (NASDAQ: PMVP) open the trading on Wednesday, with a bit cautious approach as it glided -5.03% to $1.70, before settling in for the price of $1.79 at the close. Taking a more long-term approach, PMVP posted a 52-week range of $1.17-$9.72.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 0.00%. Meanwhile, its Annual Earning per share during the time was -28.63%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 3.33%. This publicly-traded company’s shares outstanding now amounts to $51.45 million, simultaneously with a float of $40.65 million. The organization now has a market capitalization sitting at $87.45 million. At the time of writing, stock’s 50-day Moving Average stood at $1.7204, while the 200-day Moving Average is $3.8939.

PMV Pharmaceuticals Inc (PMVP) Ownership Facts and Figures

Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. PMV Pharmaceuticals Inc’s current insider ownership accounts for 20.99%, in contrast to 85.41% institutional ownership. According to the most recent insider trade that took place on Nov 22 ’23, this organization’s 10% Owner sold 87,786 shares at the rate of 2.23, making the entire transaction reach 195,763 in total value, affecting insider ownership by 0. Preceding that transaction, on Sep 15 ’23, Company’s Chief Medical Officer sold 6,291 for 6.62, making the whole transaction’s value amount to 41,646. This particular insider is now the holder of 45,909 in total.

PMV Pharmaceuticals Inc (PMVP) Earnings and Revenue Records

So, what does the last quarter earnings report of the company that was made public on 12/30/2023 suggests? It has posted -$0.31 earnings per share (EPS) beating the forecaster’s viewpoint (set at -$0.39) by $0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.39 per share during the current fiscal year.

PMV Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 3.33% and is forecasted to reach -1.53 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 23.10% through the next 5 years, which can be compared against the -28.63% growth it accomplished over the previous five years trading on the market.

PMV Pharmaceuticals Inc (NASDAQ: PMVP) Trading Performance Indicators

Let’s observe the current performance indicators for PMV Pharmaceuticals Inc (PMVP). It’s Quick Ratio in the last reported quarter now stands at 14.78. The Stock has managed to achieve an average true range (ATR) of 0.12.

In the same vein, PMVP’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.44, a figure that is expected to reach -0.37 in the next quarter, and analysts are predicting that it will be -1.53 at the market close of one year from today.

Technical Analysis of PMV Pharmaceuticals Inc (PMVP)

[PMV Pharmaceuticals Inc, PMVP] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 74.05% While, its Average True Range was 0.1183.

Raw Stochastic average of PMV Pharmaceuticals Inc (PMVP) in the period of the previous 100 days is set at 11.94%, which indicates a major fall in contrast to 46.15% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 52.59% that was lower than 78.22% volatility it exhibited in the past 100-days period.